Page last updated: 2024-08-25

zoledronic acid and Carcinoma, Ovarian Epithelial

zoledronic acid has been researched along with Carcinoma, Ovarian Epithelial in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cabillic, F; Catros, V; Daniel, P; Dessarthe, B; Henno, S; Jaffre, I; Lavoué, V; Levêque, J; Thedrez, A	1

Other Studies

1 other study(ies) available for zoledronic acid and Carcinoma, Ovarian Epithelial

Article	Year
A quantitative deficiency in peripheral blood Vγ9Vδ2 cells is a negative prognostic biomarker in ovarian cancer patients. PloS one, 2013, Volume: 8, Issue:5 Topics: Aged; Biomarkers, Tumor; Carcinoma, Ovarian Epithelial; CD3 Complex; Cell Proliferation; Cells, Cultured; Combined Modality Therapy; Diphosphates; Diphosphonates; Disease-Free Survival; Drug Resistance, Neoplasm; Humans; Imidazoles; Interferon-gamma; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Prognosis; Survival Analysis; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Regulatory; Treatment Outcome; Tumor Necrosis Factor-alpha; Zoledronic Acid	2013

Article

Year

A quantitative deficiency in peripheral blood Vγ9Vδ2 cells is a negative prognostic biomarker in ovarian cancer patients.

PloS one, 2013, Volume: 8, Issue:5

Topics: Aged; Biomarkers, Tumor; Carcinoma, Ovarian Epithelial; CD3 Complex; Cell Proliferation; Cells, Cultured; Combined Modality Therapy; Diphosphates; Diphosphonates; Disease-Free Survival; Drug Resistance, Neoplasm; Humans; Imidazoles; Interferon-gamma; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Prognosis; Survival Analysis; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Regulatory; Treatment Outcome; Tumor Necrosis Factor-alpha; Zoledronic Acid

2013